前收市價 | 1.7800 |
開市 | 2.0600 |
買盤 | 1.6400 |
賣出價 | 2.2200 |
拍板 | 27.50 |
到期日 | 2025-03-21 |
今日波幅 | 2.0600 - 2.3000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 10.69k |
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.